Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast Podcasts

Medcast Videos

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Disease Spotlight

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Articles

Cure SMA introduces tools aiding in SMA clinical trial navigation and participation empowerment.

Cure SMA Unveils Initiatives to Improve Clinical Trial Accessibility

Lindsey Lee Lair, MD, a neurologist and vice president of clinical development at Biohaven Pharmaceuticals, provided insight on an ongoing pivotal trial assessing the impacts of taldefgrobep alfa, a myostatin inhibitor, in patients with SMA.

Adding New Mechanistic Agents to SMA Treatment: the Phase 3 RESILIENT Study

In patients with relapsing-remitting MS who achieved NEDA under highly effective DMT, sNfL concentrations were low and stable, suggesting a potential role for sNfL for long-term monitoring of inflammatory disease activity.

Serum Neurofilament Light Adds Complimentary Value to Monitoring Disease Progression in Relapsing Multiple Sclerosis

Videos

The director of Dysautonomia Clinic talked about advocating for recognition and research into neurological symptoms that have long been overlooked in patients with Long COVID. [WATCH TIME: 3 minutes]

Overlooked Neurological Features Present in Long COVID: Svetlana Blitshteyn, MD, FAAN

, has been with the team since October 2019. Follow him on Twitter 

Jacqueline A. French, MD, professor of neurology at NYU Grossman School of Medicine, provided comments on a recently published study explaining the issues with diagnosing epilepsy in emergency department settings.

Importance of Nonmotor Features When Diagnosing Epilepsy in Adolescents

Chief of the Division of MS and Neuroimmunology at UConn Health.

The chief of the Division of MS and Neuroimmunology at UConn Health talked about the challenges with access to care in multiple sclerosis, particularly for marginalized communities, despite significant progress made in the field over the past decades. [WATCH TIME: 4 minutes]

A Call to Action to Address Disparities in Multiple Sclerosis Care: Jaime Imitola, MD

The associate chair for technology and innovation at the NYU Grossman School of Medicine provided commentary on a study from AAN 2024 that examined the driving factors behind burnout in neurology departments. [WATCH TIME: 4 minutes]

Addressing Potential Causes of Burnout Through Productive Solutions: Neil Busis, MD

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

Twitter

LinkedIN

YouTube

Spotlight

AAN 2024

MDA 2024

ACTRIMS 2024

Treating NMOSD: What's Next?

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

1rem

View

Updates in the Management of Relapsing Multiple Sclerosis

Fred Lublin, MD; Patricia K. Coyle, MD; Mark Freedman, MD; and Scott D. Newsome, DO, discuss a number of topics pertaining to the diagnosis of multiple sclerosis, including a focus on fatigue and its impact on quality of life.

2017 Changes to the McDonald Criteria: Diagnosing Multiple Sclerosis 

Use of MRI in Diagnosing Multiple Sclerosis 

Misdiagnosis of Multiple Sclerosis

Cerebrospinal Fluid in Diagnosing Multiple Sclerosis

Challenges in Optimally Treating Multiple Sclerosis

 QoL Issues in the Management of Multiple Sclerosis

Multiple Sclerosis Fatigue

TRIUMPHANT-MS Trial: Fatigue in MS

OPTIMUM Phase 3 Trial: Secondary End Point Effect on Fatigue

Strategies for Choosing Initial Therapy in MS

Anti-CD20 Monoclonal Antibodies for Treatment of RMS

Cladribine for Treatment of RMS

S1P Receptor Modulators for Treatment of RMS

Fumarates for Treatment of RMS

The Future of Managing Multiple Sclerosis

Peer Exchange

Clinical

EMD-22-NRD0193 - /clinical/multiple-sclerosis

 Peer Exchange video series features panels of expert physicians engaging in in-depth discussions about practice-changing treatments, challenges in care, and the future paradigm of management for neurologic diseases.

Fumarates for Treatment of RMS

EP: 1.2017 Changes to the McDonald Criteria: Diagnosing Multiple Sclerosis

EP: 2.Use of MRI in Diagnosing Multiple Sclerosis

EP: 3.Misdiagnosis of Multiple Sclerosis

EP: 4.Cerebrospinal Fluid in Diagnosing Multiple Sclerosis

EP: 5.Challenges in Optimally Treating Multiple Sclerosis

EP: 6. QoL Issues in the Management of Multiple Sclerosis

EP: 7.Multiple Sclerosis Fatigue

EP: 8.TRIUMPHANT-MS Trial: Fatigue in MS

EP: 9.OPTIMUM Phase 3 Trial: Secondary End Point Effect on Fatigue

EP: 10.Strategies for Choosing Initial Therapy in MS

EP: 11.Anti-CD20 Monoclonal Antibodies for Treatment of RMS

EP: 12.Cladribine for Treatment of RMS

EP: 13.S1P Receptor Modulators for Treatment of RMS

EP: 14.Fumarates for Treatment of RMS

EP: 15.The Future of Managing Multiple Sclerosis